31 results match your criteria: "Hôpitaux Universitaires Strasbourg[Affiliation]"
Clin Immunol
July 2024
Translational Medicine, Servier, Research and Development, Gif-Sur-Yvette, France; Centre de Recherche sur l'Inflammation, INSERM UMRS1149, Paris, France. Electronic address:
Nat Genet
November 2023
Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Phospholipase A/acyltransferase 3 (PLAAT3) is a phospholipid-modifying enzyme predominantly expressed in neural and white adipose tissue (WAT). It is a potential drug target for metabolic syndrome, as Plaat3 deficiency in mice protects against diet-induced obesity. We identified seven patients from four unrelated consanguineous families, with homozygous loss-of-function variants in PLAAT3, who presented with a lipodystrophy syndrome with loss of fat varying from partial to generalized and associated with metabolic complications, as well as variable neurological features including demyelinating neuropathy and intellectual disability.
View Article and Find Full Text PDFLancet Neurol
December 2022
Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, Faculty of Brain Sciences, London, UK.
There is no consensus regarding the classification of optic neuritis, and precise diagnostic criteria are not available. This reality means that the diagnosis of disorders that have optic neuritis as the first manifestation can be challenging. Accurate diagnosis of optic neuritis at presentation can facilitate the timely treatment of individuals with multiple sclerosis, neuromyelitis optica spectrum disorder, or myelin oligodendrocyte glycoprotein antibody-associated disease.
View Article and Find Full Text PDFJ Rheumatol
January 2023
F. Fayet, BSc, M. Soubrier, MD, PhD, M. Rodère, BSc, Service de Rhumatologie, Centre Hospitalier Universitaire Gabriel-Montpied, Clermont-Ferrand.
Objective: To develop and validate a patient knowledge questionnaire regarding axial spondyloarthritis (axSpA).
Methods: Knowledge considered essential for patients with axSpA was identified through Delphi rounds among rheumatologists, healthcare professionals (HCPs), and patients, then reformulated to develop the knowledge questionnaire. Cross-sectional validation was performed in 14 rheumatology departments to assess internal validity (Kuder-Richardson coefficient), external validity, acceptability, reproducibility (Lin concordance correlation coefficient), and sensitivity to change (knowledge score before vs after patient education sessions and effect size).
Joint Bone Spine
July 2021
Inserm 1227, LabEx IGO, rhumatologie, centre de référence maladies rares CERAINO, université de Bretagne Occidentale, CHU de Brest, 29200 Brest, France. Electronic address:
Bone Marrow Transplant
April 2021
Sorbonne University, Department of Clinical Hematology and Cellular Therapy, Saint Antoine Hospital, INSERM UMR 938, Paris, France.
Biol Blood Marrow Transplant
May 2020
Department of Hematology-BMT, Hopital St Antoine, Paris, France.
Allogeneic hematopoietic cell transplantation (HCT) is recommended in high-risk patients with T cell acute lymphoblastic leukemia (T-ALL). For patients without an HLA-identical donor, haploidentical (haplo-) HCT is becoming the leading source of stem cell donation. However, data are scarce on predictive factors for outcome in that setting.
View Article and Find Full Text PDFJ Clin Invest
February 2020
Department of Medicine II, University Hospital Freiburg, Freiburg, Germany.
BACKGROUNDChronic hepatitis C virus (HCV) infection is characterized by a severe impairment of HCV-specific CD4+ T cell help that is driven by chronic antigen stimulation. We aimed to study the fate of HCV-specific CD4+ T cells after virus elimination.METHODSHCV-specific CD4+ T cell responses were longitudinally analyzed using MHC class II tetramer technology, multicolor flow cytometry, and RNA sequencing in a cohort of patients chronically infected with HCV undergoing therapy with direct-acting antivirals.
View Article and Find Full Text PDFJ Clin Virol
November 2019
Laboratoire de Virologie, Hôpital Brabois, CHRU de Nancy, Vandoeuvre-les-Nancy, France; LCPME (Laboratoire de Chimie Physique et Microbiologie pour les Matériaux et l'Environnement), UMR 7564, Faculté de Pharmacie, Nancy, F-54000, France. Electronic address:
Background: "Treatment as Prevention" (TasP) aims to reduce new HIV infections through higher enrolment on suppressive antiretroviral therapy (ART).
Objectives: We studied the current epidemic and possible impact of TasP in a French HIV cohort including MSM and migrant subjects.
Study Design: Socio-demographic, clinical and laboratory variables were collected during the follow-up of 6995 HIV-infected patients.
Ann Rheum Dis
December 2018
Department of Rheumatology, Université Paris-Sud, AP-HP, Hôpitaux Universitaires Paris-Sud, INSERM U1184, Le Kremlin Bicêtre, France.
Purpose: The outcome of desmoid-type fibromatosis (DTF) is unpredictable. Currently, a wait-and-see approach tends to replace large en bloc resection as the first therapeutic approach. Nevertheless, there are no validated factors to guide the treatment choice.
View Article and Find Full Text PDFPLoS One
June 2017
Université des Antilles, Faculté de Médecine Hyacinthe Bastaraud, EA 4537, Pointe-à-Pitre, France.
Medicine (Baltimore)
October 2016
Aix-Marseille University, APHM Hôpital Sainte-Marguerite, Immuno-Hematology Clinic Inserm U912 (SESSTIM), Marseille CHU Hotel Dieu, Infectious Diseases Unit, Nantes Inserm Université de Toulouse III, UMR1027, Toulouse APHP- Necker Hospital, Infectious Diseases Department, Necker-Pasteur Infectious Diseases Center, IHU Imagine Pasteur Institut, Medical Care Center, Necker-Pasteur Infectious Diseases Center France Université Paris Descartes, Sorbonne Paris Cité, Paris Infectious Diseases Department, CHU of Nice, University Nice Sophia-Antipolis Hôpitaux Universitaires Strasbourg, Center for HIV care, Strasbourg Hospital Tourcoing, Infectious Disease Unit, Tourcoing INSERM, UMR 1027, Toulouse III University, Toulouse, F-31000, France; CHU Toulouse, COREVIH Toulouse, F-31000 AP-HP, Hospital Pitie-Salpetriere, Department of Infectious Diseases UPMC Univ Paris UMRS 943, Paris CHU de Fort de France, Service de maladies infectieuses et tropicales, Martinique Université des Antilles, Faculté de Médecine Hyacinthe Bastaraud, EA 4537; Centre Hospitalier Universitaire de Pointe-à-Pitre, Inserm CIC1424, Service de Maladies Infectieuses et Tropicales, Dermatologie, Médecine Interne, Pointe-à-Pitre, France.
The aim of the study was to investigate the impact of first-line combined antiretroviral therapy (cART) regimen on the course of CD8 T-cell counts in human immunodeficiency virus (HIV)-infected patients.A retrospective observational study conducted on the French DAT'AIDS Cohort of HIV-infected patients.We selected 605 patients initiating a first-line cART between 2002 and 2009, and which achieved a sustained undetectable HIV plasma viral load (pVL) for at least 12 months without cART modification.
View Article and Find Full Text PDFPresse Med
April 2016
Université de Strasbourg, faculté de médecine de Strasbourg, hôpitaux universitaires de strasbourg et FMTS, hôpital de Hautepierre, service de réanimation médicale, 1, avenue Molière, 67098 Strasbourg cedex, France.
Lancet Infect Dis
November 2015
Institut National de la Santé et de la Recherche Médicale, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France; Sorbonne Universités, UPMC Université Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France; Département de santé publique, Groupe Hospitalier Est Parisien, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Background: Revaccination with double-dose hepatitis B vaccine has been recommended in HIV-infected patients who do not respond to standard vaccination, but has not yet been assessed. We aimed to compare the safety and immunogenicity of a reinforced hepatitis B revaccination protocol with the standard revaccination schedule in HIV-infected patients not responding to primary vaccination.
Methods: We did this multicentre, open-label, randomised controlled trial, at 53 centres in France.
Eur J Cancer
April 2015
Department of Medical Oncology, Centre Léon Bérard, Lyon, France. Electronic address:
Aim: The French Sarcoma Group performed this retrospective analysis of the 'RetrospectYon' database with data of patients with recurrent advanced soft tissue sarcoma (STS) treated with trabectedin 1.5 mg/m(2) as a 24-h infusion every three weeks.
Methods: Patients who achieved non-progressive disease after six initial cycles could receive long-term trabectedin treatment until disease progression.
Infect Dis (Lond)
February 2015
From the Le Trait d'Union, Hôpitaux Universitaires Strasbourg.
Background: The prevalence of osteopenia and osteoporosis is increased in human immunodeficiency virus (HIV)-infected patients. The pathogenesis of this low bone mineral density (BMD) is multifactorial.
Methods: We conducted a prospective study over a 2-year period of the BMD in non-treated ARV-naïve HIV-infected-males, in comparison to HIV-infected males commencing a first ARV treatment, and analyzed the evolution of bone turnover markers.
Vaccine
January 2014
Université Paris-Diderot, Sorbonne Paris, Cité, Paris, France; Service d'Hématologie-Greffe de Moelle, Hôpital Saint-Louis, AP-HP, Paris, France.
Background: The present study evaluated immunogenicity and tolerance of two-dose influenza A/H1N1pdm09 vaccination in allogeneic hematopoietic stem cell transplantation (HSCT) recipients, and compared the vaccine-induced humoral response to that triggered by natural infection in another group of HSCT patients.
Methods: Adult allogeneic HSCT recipients vaccinated with two doses of influenza A/H1N1pdm09 vaccine, separated by 3 weeks, and patients with proven influenza A/H1N1pdm09 infection were included. Antibody responses were measured by hemagglutination-inhibition assay 1) on days 0, 21, 42 and 6 months after the first vaccine injection in vaccinated patients and 2) before pandemic and after influenza A/H1N1pdm09 infection, in patients presented natural infection.
Eur Respir J
February 2009
Dept of Chest Diseases, Hôpitaux Universitaires Strasbourg, 1 place de l'Hôpital, BP 426, 67091 Strasbourg, France.
The epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) erlotinib improves survival of lung cancer as second- or third-line therapy. However, after an initial response, most patients will recur, particularly within the central nervous system. The present study reports the case of a 27-yr-old nonsmoking male presenting with a metastatic lung adenocarcinoma with EGFR exon 19 deletion, associated with sensitivity to EGFR-TKI.
View Article and Find Full Text PDFN Engl J Med
January 2008
Hopitaux Universitaires Strasbourg, F-67091 Strasbourg, France.
Neuroimage
June 2005
Clinique Psychiatrique-INSERM U405, Hôpitaux Universitaires-Strasbourg, France.
The disconnectivity hypothesis proposes that schizophrenia results from poor or miswired anatomical connections. Theoretically, its functional counterpart should be disintegration. Integration is thought to allow segregated neurons to interact as a coherent whole, referred to as the "core", while the non-interacting part of the brain is referred to as the "rest".
View Article and Find Full Text PDFJ Acquir Immune Defic Syndr
December 2004
Hôpitaux Universitaires Strasbourg, Strasbourg, France.
A combination of 2 nucleoside analogues and 1 protease inhibitor is usually recommended in postexposure prophylaxis. Because of the complex treatment schedule and frequent adverse effects, however, this regimen is often not completed. Therefore, since January 2000, we have used nevirapine (NVP), 200 mg/d, for only 4 days in combination with 2 nucleoside analogues for 1 month to improve adherence and completion rates.
View Article and Find Full Text PDFGrowth Horm IGF Res
June 2004
Institut de Génétique et Biologie Moléculaire et Cellulaire, INSERM/CNRS/Université Louis Pasteur, Faculté de Médecine and Hôpitaux Universitaires Strasbourg, Illkirch-Cedex, Strasbourg 67404, France.
The Fragile X (FRAXA) syndrome is the most common cause of familial (monogenic) mental retardation and is widespread in human populations. This syndrome is characterised by an unusual mode of transmission for an X-linked disease. In affected families, one frequently finds clinically normal transmitting males, whose daughters - also clinically normal - have a high risk of having affected children.
View Article and Find Full Text PDFMedicine (Baltimore)
January 2003
Clinique Dermatologique, Sevice de Médecine Interne, Hôpitaux Universitaires Strasbourg, France.
We describe an easily recognizable and previously not individualized clinical syndrome that can reveal solitary plasmacytoma of bone. We report 4 patients with a slowly extending violaceous skin patch overlying a solitary plasmacytoma of bone, associated with enlarged regional lymph nodes. Biopsies of the cutaneous lesion and the lymph nodes were not specific, although increased dermal mucin deposition and vascular proliferation were present in all skin specimens.
View Article and Find Full Text PDFRev Neurol (Paris)
October 2002
Service des Maladies Infectieuses et Tropicales. Hôpitaux Universitaires Strasbourg, France.
Some microorganisms transmitted to man via tick bite are responsible for infections, which can be associated with neuro-meningeal complications. TBE virus is the most frequent virus associated with potentially severe neurological lesions. No treatment is available so far.
View Article and Find Full Text PDF